Researchers Make Progress in Aging Treatment with Promising Mouse Study
November 29, 2025171 ViewsRead Time: 2 minutes
Font Size
16
A team of researchers has reported a significant advancement in aging treatment, achieving promising results in mouse experiments. They anticipate that these findings may soon facilitate human clinical trials aimed at addressing aging and enhancing vitality.
The Mechanism of Aging
As individuals age, the efficiency of blood-forming stem cells declines, which can compromise the immune system and elevate the risk of conditions such as anemia and cancer. A study featured in Science Alert reveals that researchers have identified a method to restore these stem cells to their original functionality, potentially aiding in the treatment of blood deficiencies and age-related immune decline.
The Function of Lysosomes
According to the researchers, aging stem cells exhibit dysfunction in lysosomes—cellular structures that recycle proteins and fats. A collaborative study between the Icahn School of Medicine at Mount Sinai in the U.S. and Paris City University found that aging leads to impaired lysosomal function in blood-forming stem cells, resulting in their hyperactivity compared to younger cells.
Mouse Experiments
Sagi Ghafari, a stem cell biologist, conducted experiments on aging mice and discovered that their stem cells had lysosomes that were excessively acidic and dysfunctional, hindering regeneration. By administering a compound known as Concanamycin A, the team successfully normalized the lysosomal function and acidity.
Study Outcomes
After treating the stem cells from the mice and reintroducing them into their bodies, the ability of the tissues to generate new blood cells increased eightfold. The treated cells displayed rejuvenated characteristics, regaining their capacity to regenerate and produce balanced blood cells.
Ghafari emphasized that these results suggest that aging in blood stem cells is not irreversible; by targeting lysosomal hyperactivity, it is possible to rejuvenate these cells, thereby enhancing blood cell renewal and immune function.
The Mechanism of Aging
As individuals age, the efficiency of blood-forming stem cells declines, which can compromise the immune system and elevate the risk of conditions such as anemia and cancer. A study featured in Science Alert reveals that researchers have identified a method to restore these stem cells to their original functionality, potentially aiding in the treatment of blood deficiencies and age-related immune decline.
The Function of Lysosomes
According to the researchers, aging stem cells exhibit dysfunction in lysosomes—cellular structures that recycle proteins and fats. A collaborative study between the Icahn School of Medicine at Mount Sinai in the U.S. and Paris City University found that aging leads to impaired lysosomal function in blood-forming stem cells, resulting in their hyperactivity compared to younger cells.
Mouse Experiments
Sagi Ghafari, a stem cell biologist, conducted experiments on aging mice and discovered that their stem cells had lysosomes that were excessively acidic and dysfunctional, hindering regeneration. By administering a compound known as Concanamycin A, the team successfully normalized the lysosomal function and acidity.
Study Outcomes
After treating the stem cells from the mice and reintroducing them into their bodies, the ability of the tissues to generate new blood cells increased eightfold. The treated cells displayed rejuvenated characteristics, regaining their capacity to regenerate and produce balanced blood cells.
Ghafari emphasized that these results suggest that aging in blood stem cells is not irreversible; by targeting lysosomal hyperactivity, it is possible to rejuvenate these cells, thereby enhancing blood cell renewal and immune function.
